Bluestar Genomics

The company said that the certification will enable it to perform its epigenomic pancreatic cancer test within its own laboratory.

The complaint focuses on a recent patent filed by Chunxiao Song, the consultant, alleging that it falls within the terms of his contract with Bluestar. 

The San Diego-based early cancer detection firm has also appointed Felix Fang and Craig Venter to its scientific advisory board.